Metraipolis › archive › dc_c581f7aaa8a0

Secondary Loss of Response to Dopamine Receptor Agonists in the Treatment of Macroprolactinoma — Europe PMC PMID:41080303

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41080303
DOI: 10.7759/cureus.92046
License (as archived): solo-consultazione
Archived: 2026-11-10T00:27:17.646Z
SHA-256 of the archived text: 20002599f6de1489719fc2c2516af5d56b3d118377b9ec46b0562756e5e37f2e
Stable URL of this page: https://metraipolis.com/documento/dc_c581f7aaa8a0

How to cite

Secondary Loss of Response to Dopamine Receptor Agonists in the Treatment of Macroprolactinoma — Europe PMC PMID:41080303 — Europe PMC (en), https://europepmc.org/article/MED/41080303 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c581f7aaa8a0 (Metraipolis archive dc_c581f7aaa8a0, sha256 20002599f6de1489719fc2c2516af5d56b3d118377b9ec46b0562756e5e37f2e)

BibTeX

@misc{dcc581f7aaa8a0,
  title = {Secondary Loss of Response to Dopamine Receptor Agonists in the Treatment of Macroprolactinoma — Europe PMC PMID:41080303},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41080303},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c581f7aaa8a0; sha256 20002599f6de1489719fc2c2516af5d56b3d118377b9ec46b0562756e5e37f2e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41080303. Agents can read the archived copy with the MCP tool read_document.